Biotech Could See More M&A Speculation Following DNA/TNOX Deal

We could see renewed M&A speculation in the biotech sector tomorrow following Genentech's (NYSE: DNA) deal to buy Tanox Inc. (Nasdaq: TNOX) for $20 per share, a 46% premium to today's closing price.